Baroreflex sensitivity and malignant ventricular arrhythmias in patients with acute myocardial infarction;SENSIBILIDAD BARORREFLEJA Y ARRITMIAS VENTRICULARES MALIGNAS EN LA FASE AGUDA DE PACIENTES CON INFARTO DE MIOCARDIO

Medicina Intensiva

Volumn 20, Issue 1, 1996, Pages 20-25

  Garcia Diaz F ^a   Vazquez Garcia R ^b   Fajardo Lopez Cuervo J ^a   Gimenez Raurell J ^a   Ramos Gonzalez Serna A ^a  

^a Hospital Vigil de Quinones   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Acute myocardial infarction; Autonomic nervous system; Baroreflex sensitivity; Phenylephrine; Ventricular arrhythmias

Indexed keywords

PHENYLEPHRINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRESSORECEPTOR REFLEX;

EID: 0030023257     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Malliani A, Schwartz PJ, Zanchetti A. Neural mechanism in life-threatening arrhytmias. Am Heart J 1980: 100:705-715.
2. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85: (suppl I) 77-90.
3. Ewing DJ, Neilson JMM, Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J 1984; 52:396-402
4. Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward DE, et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 1992; 67:129-137.
5. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality amongst patients with a first myocardial infarction, a prospective study. Circulation 1988; 78:816-824.
6. Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurement of heart rate variability Cardiology Clinics 1992;10:487-498.
7. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: A quantitative method of assessing baroreflex sensitivity. Circ Res 1969; 24:109-121.
8. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Hanjorg J. Assessment of coronary artery patency after thrombolityc therapy: accurate prediction utilizing the combined analysis of three markers. J Am Coll Cardiol 1991; 18:44-49
9. Eckberg DL, Halliwill JR, Smith ML, Minist AJ. Autonomic complicity in catastrophic cardiac rythms. En: Hainswhort R. Mark AL. eds. Cardiovascular reflex control in health and disease. London: WB Saunders. 1993; 397-423.
10. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:1.165-1.170.
11. Myers RW, Pearlman A, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, et al. Beneficial effects of vagal stimulation and bradycardia during experimental myocardial ischemia. Circulation 1974;49:943-947.
12. Webb SW, Adgey AAJ, Pantridge JF. Autonomic disturbance at onset of acute myocardial infarction. Br Med J 1972, 3:89-92.
13. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Feriari GM, Billman GE, Foreman RD. Autonomic mechanism and sudden death: New insights from analysis of barorreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78:969-979.
14. Schwartz PJ, Zaza A, Pala M, Locati E, Beria G, Zanchetti A. Baroreflex sensitivity and its evolution during the first year after myocardial infarction. J Am Coll Cardiol 1988, 12: 629-636.
15. Myerburg RJ, Kessler KM. Interian A Jr. Clinical and experimental pathophysiology of sudden death. En:Zipes DP, Jalife J. eds. Cardiac Electrophysiology: From the Cell to Beside. Philadelphia: WB Saunder Co., 1990;666-678.
16. Farrell TG, Paul V, Cripps TR, Malik M, Bennett ED. Ward E, et al. Baroreflex sensitivity and electrophysiological correlates in patients after myocardial infarction. Circulation 1991;83: 945-952.
17. Pedretti R, Colombo E, Sarzi Braga S, Carú B. Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1993; 72: 384-392.
18. Gaetano M, De Ferrari, Landolina M, Mantica M, Manfredini R. Pessano P, et al. Barreceptor reflex sensitivity correlates with the hemodynamic tolerability of sustained ventricular tachycardia (Abstract 1444) from the 67th Scientific Sessions, American Heart Association, Dallas, TX, November 14-17, 1994. Circulation 1994; 90, Num 4, Part 2, I-268
19. β-Blocker Heart Attack Trial Research Group. A randomized trial of propanolol in patients with acute myocardial infarction 1. Mortality result. JAMA 1982; 247: 1.707-1.714.
20. Eckberg DL, Drabinsky M, Braunwald E Defective cardiac parasympathetic control in patients with heart disease N Engl J Med 1971; 285:877-883.
21. The Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309:331-336.
22. Vanoli E, La Rovere MT, Mortara A, Schwartz PJ. Methods for assesment of vagal reflexes. En: Levi MN, Schwartz PJ, eds. Vagal Control of The Heart: Experimental basis and Clinical implications. Armonk, NY: Futura Publishing Co, 1994; 455-480.
23. Parmer RJ, Cervenka JH, Stone RA. Baroreflex sensitivity and heredity in essential hypertension. Circulation 1992;85:496-503
24. Smith NT, Wesseling KH, DeWit B. Evaluation of two prototype devices producing noninvasive, pulsatile, calibrated blood pressure measurement from a finger. J Clin Monit 1985; 1:17-29.
25. La Rovere MT, Mortara A, Bigger JT Jr, Marcus F, Buonamica PG, Colombo E, et al for the ATRAMI Investigators. Reliability of non-invasive assessment of baroreflex sensitivity after myocardial infarction. ATRAMI, a international multicenter prospective study (abstract 1391). Eur Heart J 1993, 14 (suppl):253.
26. De Ferrari, Mantica M, Vanoli E, Hull SS, Schwartz PJ. Scopolamine increases vagal tone and vagal reflexes in patients after acute myocardial infarction. J Am Coll Cardiol 1993; 22:1.327-1.334.
27. Hull SS, Vanoli E, Adamson PB, De Ferrari GM, Foreman R, Schwartz PJ. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995; 91:2.516-2.519.